Galmed Pharmaceuticals Stock Price - GLMD

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Galmed Pharmaceuticals Ltd GLMD NASDAQ Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.00 0.0% 6.20 0.00 0.00 0.00 6.20 04:00:00
Bid Price Ask Price Spread Spread % News
3.50 14.49 10.99 75.85% - -
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.00 USD

Galmed Pharmaceuticals Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 130.97M 21.12M $ -9.86M -0.57 - 21.12M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Galmed Pharmaceuticals News

Date Time Source News Article
11/06/201907:11Edgar (US Regulatory)Report of Foreign Issuer (6-k)
11/06/201907:00PR Newswire (US)Galmed Pharmaceuticals Provides Business Update and Reports..
10/31/201909:04Edgar (US Regulatory)Report of Foreign Issuer (6-k)
10/31/201908:30PR Newswire (US)Galmed Pharmaceuticals to Present New Data on Aramchol..
10/30/201908:30PR Newswire (US)Galmed Pharmaceuticals to Report Third Quarter 2019..
9/26/201908:12Edgar (US Regulatory)Report of Foreign Issuer (6-k)
9/26/201908:00PR Newswire (US)Galmed Pharmaceuticals Initiated ARMOR, a Phase 3/4..

Latest GLMD Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GLMD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week6.957.155.806.38188,704-0.75-10.79%
1 Month4.467.384.306.09173,6501.7439.01%
3 Months4.927.383.41795.13110,1261.2826.02%
6 Months5.727.703.41795.3187,7290.488.39%
1 Year8.229.743.41796.7198,871-2.02-24.57%
3 Years3.3627.063.0411.50139,4602.8484.52%
5 Years4.9027.062.7810.66101,8411.3026.53%

Galmed Pharmaceuticals Description

Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development and commercialization of once-daily, oral therapy for the treatment of liver diseases and cholesterol gallstones utilizing its synthetic fatty-acid/bile-acid conjugate (FABAC), called aramchol. Its product, aramchol, is a disease-modifying treatment for fatty liver disorders, including Non-Alcoholic Steato-hepatitis. Aramchol affects liver fat metabolism and has been shown in a Phase IIa clinical study to reduce liver fat content, as well as improve metabolic parameters associated with Nonalcoholic steatohepatitis.
Your Recent History
NASDAQ
GLMD
Galmed Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191212 11:54:07